Deliang Guo, PhD
College of Medicine
Glioblastoma ● Brain Cancer ● Cancer ● Melanoma ● Glioma ● Hypertension
Deliang Guo, PhD, is an associate professor in the Department of Radiation Oncology at Ohio State and a member of the Translational Therapeutics Program at the OSUCCC – James, where he focuses his work on determining the key molecular targets in cancer metabolism and translating those findings into the clinical setting.He is co-holder of a patent on a novel strategy for targeting EGFR-activated glioblastoma, the most lethal form of brain cancer. His recent research includes work that first identifies that lipid droplets are unique organelles enriched in glioblastoma patient tumor tissues and suggests a novel therapeutic strategy to treat this disease by interrupting lipid-droplet metabolism. He has also been part of research targeting SREBP-1-driven lipid metabolism to treat cancer. Dr. Guo has co-authored a dozen articles in prestigious publications, such as Neuro-Oncology, Current Pharmaceutical Design, Clinical Cancer Research and Journal of Translational Medicine. He has also made presentations to various organizations, including the American Heart Association and American Association for Cancer Research.
544 Tzagournis Medical Research Facility
420 W 12th Ave, Columbus, OH 43210